EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions

Fabrizio Settepani iD, Aldo Cannata, Igor Belluschi, Giulia Pinuccia Pisani, Michele Giovanni Mondino, Andrea Garascia, Claudio Francesco Russo

Interdisciplinary CardioVascular and Thoracic Surgery · 2026

DOI: 10.1093/icvts/ivaf301 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2026. Verfasst von Fabrizio Settepani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery and Heart Transplant Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria T…. Hauptthemen laut MEDLINE: Heart Transplantation, Primary Graft Dysfunction, Cardioplegic Solutions, Heart Arrest, Induced. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We analysed our long-term experience with heart transplantation (Htx) utilizing 3 different cardioplegic solutions.

Methods

During a 20-year period, 538 adult individuals underwent isolated Htx at our institution. Ten cases in which the Organ Care System TransMedics Inc was utilized were excluded, resulting in a final cohort of 528 individuals. Patients were stratified into 3 groups according to the donor heart cardioplegic solution: Celsior (n = 301; reference group), HTK-Custodiol (n = 88), and St Thomas (n = 139). Mean follow-up period was 6.2 ± 5.5 years (maximum 20 years).

Results

The rate of severe primary graft dysfunction (PGD) was 10.2% in the HTK-Custodiol group, significantly higher than the reference group (4.5%; P < .040). Overall, in-hospital mortality was 12.9%: 13.6% in the HTK-Custodiol group and 12.9% in the St Thomas group, comparable to the reference group (P = .803 and P = .924). Survival at 1, 5, and 12 years in the Celsior and HTK-Custodiol groups was 82.6 ± 2.2% vs 85.2±3.8%, 79.4 ± 2.4% vs 82.1 ± 4.3%, and 66.8 ± 3.3% vs 62.9 ± 7.3%, respectively (P = .706). Survival at 1, 5, and 12 years in the St Tomas group was 81.5 ± 3.4%, 71.9 ± 4.1%, and 65.5 ± 5.2%, respectively, comparable to the reference group (P = .640). Post-transplant rejection rate was similar among the groups.

Conclusions

The use of HTK-Custodiol solution was associated with a significantly higher incidence of PGD when compared to Celsior solution, although this data had no impact on in-hospital mortality. Long-term survival and post-transplant rejection were comparable among the 3 groups. HTK-Custodiol solution should be used with caution for preservation of donor hearts. ERB Approval Number 215-29042020; May 5, 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationPrimary Graft DysfunctionCardioplegic SolutionsHeart Arrest, InducedHumansMaleFemaleMiddle AgedAdultMannitolDisaccharidesHistidineTreatment OutcomeHospital MortalityGlutathioneRetrospective StudiesElectrolytesTime FactorsPotassium ChlorideProcaineGlutamatesGlucoseRisk FactorsRaffinose

Stichwörter der Autor:innen

cardiac preservation solutionheart transplantationlong-term resultsmyocardial protectionprimary graft dysfunction

Substanzen

CelsiorMannitolDisaccharidesHistidineCardioplegic SolutionsGlutathioneElectrolytesPotassium ChlorideProcaineGlutamates

Autor:innen und Institutionen

  • Cardiac Surgery and Heart Transplant Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Ital…
  • Intensive Care Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy.
  • Cardiology 2 Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy.

ORCID-Profile: Fabrizio Settepani

Zitieren

APA

Settepani, F., Cannata, A., Belluschi, I., Pisani, G. P., Mondino, M. G., Garascia, A., & Russo, C. F. (2026). Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf301

Vancouver

Settepani F, Cannata A, Belluschi I, Pisani GP, Mondino MG, Garascia A, et al. Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivaf301

BibTeX
@article{Settepani2026,
  author = {Settepani, Fabrizio and Cannata, Aldo and Belluschi, Igor and Pisani, Giulia Pinuccia and Mondino, Michele Giovanni and Garascia, Andrea and Russo, Claudio Francesco},
  title = {Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  doi = {10.1093/icvts/ivaf301}
}
Kostenlos starten →